Radioimmunotherapy based conditioning regimens for stem cell transplantation

Por Zhang, Michele, Gopal, Ajay K.
Publicado em 2008

Relapsed Mantle Cell Lymphoma Presenting as “Sister Mary Joseph Nodule”

Por Vaughn, Jennifer E., Gopal, Ajay K.
Publicado em 2010

Allogeneic hematopoietic cell transplantation in mantle cell lymphoma

Por Cassaday, Ryan D., Gopal, Ajay K.
Publicado em 2012

Treatment of relapsed classical Hodgkin lymphoma in the brentuximab vedotin era

Por Graf, Solomon A., Gopal, Ajay K.
Publicado no Hematology Am Soc Hematol Educ Program (2014)

Where does transplant fit in the age of targeted therapies?

Por Chow, Victor A., Gopal, Ajay K.
Publicado no Hematology Am Soc Hematol Educ Program (2019)

Treatment strategies for Hodgkin lymphoma recurring following autologous hematopoietic stem cell transplantation

Por Currin, Erin-Siobhain R., Gopal, Ajay K.
Publicado em 2012

Targeted Drugs as Maintenance Therapy after Autologous Stem Cell Transplantation in Patients with Mantle Cell Lymphoma

Por Yan, Fengting, Gopal, Ajay K., Graf, Solomon A.
Publicado no Pharmaceuticals (Basel) (2017)

Translating anti-CD19 CAR T-cell therapy into clinical practice for relapsed/refractory diffuse large B-cell lymphoma

Por Chow, Victor A., Shadman, Mazyar, Gopal, Ajay K.
Publicado no Blood (2018)

Controversies in the Treatment of Follicular Lymphoma

Por Hübel, Kai, Ghielmini, Michele, Ladetto, Marco, Gopal, Ajay K.
Publicado no Hemasphere (2020)

Spontaneous Remission of an Untreated, MYC and BCL2 Coexpressing, High-Grade B-Cell Lymphoma: A Case Report and Literature Review

Por Potts, D. Alan, Fromm, Jonathan R., Gopal, Ajay K., Cassaday, Ryan D.
Publicado no Case Rep Hematol (2017)

(131)I anti-CD45 radioimmunotherapy effectively targets and treats T-cell non-Hodgkin lymphoma

Por Gopal, Ajay K., Pagel, John M., Fromm, Jonathan R., Wilbur, Shani, Press, Oliver W.
Publicado em 2009

Rituximab blocks binding of radiolabeled anti-CD20 antibodies (Ab) but not radiolabeled anti-CD45 Ab

Por Gopal, Ajay K., Press, Oliver W., Wilbur, Shani M., Maloney, David G., Pagel, John M.
Publicado em 2008

A Phase II, Single-Arm, Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of P276-00, a Cyclin Dependent Kinase Inhibitor, in Patients with Relapsed or Refractory M...

Por Cassaday, Ryan D., Goy, Andre, Advani, Suresh, Chawla, Purvi, Nachankar, Rajesh, Gandhi, Mansi, Gopal, Ajay K.
Publicado no Clin Lymphoma Myeloma Leuk (2015)

Allogeneic Hematopoietic Cell Transplantation in Patients with Myelodysplastic Syndrome and Concurrent Lymphoid Malignancy

Por Zimmerman, Zachary, Scott, Bart L., Gopal, Ajay K., Sandmaier, Brenda M., Maloney, David G., Deeg, H. Joachim
Publicado em 2011

The Effective Use of Plerixafor as a Real-Time Rescue Strategy for Patients Poorly Mobilizing Autologous CD34+ cells

Por Gopal, Ajay K., Karami, Mehdi, Mayor, JoAl, Macebeo, Mylene, Linenberger, Michael, Bensinger, William I, Holmberg, Leona
Publicado em 2012

Androgen Receptor Expression in Mantle Cell Lymphoma: Potential Novel Therapeutic Implications

Por Mostaghel, Elahe A, Martin, Paul S, Mongovin, Stephen, Frayo, Shani, Zhang, Ailin, Edlefsen, Kerstin L, Press, Oliver W, Gopal, Ajay K
Publicado no Exp Hematol (2017)

Management of venous thromboembolism during thrombocytopenia after autologous hematopoietic cell transplantation

Por Li, Ang, Davis, Chris, Wu, Qian, Li, Shan, Kesten, Madeline F., Holmberg, Leona A., Gopal, Ajay K., Garcia, David A.
Publicado no Blood Adv (2017)

Brentuximab vedotin enables successful reduced-intensity allogeneic hematopoietic cell transplantation in patients with relapsed or refractory Hodgkin lymphoma

Por Chen, Robert, Palmer, Joycelynne M., Thomas, Sandra H., Tsai, Ni-Chun, Farol, Len, Nademanee, Auayporn, Forman, Stephen J., Gopal, Ajay K.
Publicado em 2012

(131)I-Tositumomab Myeloablative Radioimmunotherapy for Non-Hodgkin Lymphoma: Radiation Dose to Testes

Por Hattori, Naoya, Gopal, Ajay K., Shields, Andrew T., Fisher, Darrell R., Gooley, Ted, Pagel, John M, Press, Oliver W., Rajendran, Joseph G.
Publicado em 2012

Bortezomib and Fenretinide Induce Synergistic Cytotoxicity in Mantle Cell Lymphoma Via Apoptosis, Cell Cycle Dysregulation, and IκBα Kinase Down-regulation

Por Cowan, Andrew J., Frayo, Shani L., Press, Oliver W., Palanca-Wessels, Maria C., Pagel, John M., Green, Damian J., Gopal, Ajay K.
Publicado no Anticancer Drugs (2015)